US officials probe a new layer in opaque drug pricing, supply system
US authorities are looking into new groups that were formed to negotiate drug discounts but may actually be further obscuring how much the medicines cost.
By John Tozzi, bloomberg
Officials are working to pierce multiplying, opaque layers between the companies that make medicines and the people who take them. Cigna Group, CVS Health Corp. and UnitedHealth Group Inc. have long controlled the largest pharmacy benefit managers, or PBMs, that traditionally negotiated rebates with drugmakers. In recent years, those companies have each launched new entities called group purchasing organizations, or GPOs, to take over that job.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
